Our Portfolio

Molecular Geriatrics Corporation

John DeBernardis | IL, United States

Project Overview

Biotechnology/For Profit Organization Type
$51,470 Funding Amount
7/24/00 — 4/22/10 Project Duration
Drug Discovery Program
High Throughput Screening Therapeutic Stage
Closed Status

Molecular Geriatrics Corporation

John DeBernardis | IL, United States

Novel Therapeutic Screening Technology for Alzheimer's Disease

GET IN TOUCH

Alzheimer's Drug Discovery Foundation

A GuideStar-Rated Charity

57 West 57th Street, Suite 904
New York, NY 10019
info@alzdiscovery.org
212.901.8000

© Copyright 2026. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).